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Abstract 
Objective: In dental treatments, use of carriers for targeted antibiotic delivery would be optimal to 
efficiently decrease microbial count. In this study, gentamicin was loaded into polylactic co-glycolic 
acid (PLGA) microspheres and its release pattern was evaluated for 20 days. 
Methods: In this experimental study, PLGA microspheres loaded with gentamycin were produced 
by the W/O/W method. The correct morphology of loaded microspheres was ensured using scanning 
electron microscopy (SEM). The rate of drug release from polymeric microspheres into the 
phosphate buffered saline (PBS) solution was measured during a 20-day period using spectroscopy. 
Data were analyzed using one-way ANOVA. 
Results: SEM micrographs showed that the produced microspheres had smooth and nonporous 
surfaces and 30-micron diameter. Assessment of the pattern of drug release from the PLGA 
microspheres loaded with gentamycin revealed a burst release on day six followed by a stable 
pattern of release until day 20. 
Conclusion: Considering the biocompatibility of PLGA and optimal pattern of drug release, PLGA 
microspheres loaded with gentamicin can be successfully used for infection control and reduction of 
microbial count in dental treatments. 
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Antibiotics are a group of drugs widely used for 
treatment of infections. Antibiotics have a short 
half-life and variable side effects. Designing 
drug release systems that enable effective and 
controlled drug delivery over a long period of 
time is a necessity for medical applications. 
Antibiotics are commonly administered 
systemically and locally in medicine and 
dentistry.  
Direct pulp capping with the use of pulp capping 
agents is a common treatment modality for 
traumatic or mechanical pulp exposures. In this 
treatment, the exposed pulp is covered with a 
specific pulp capping agent that induces the 
formation of reparative dentin at the exposure 
site. The pulp tissue then recesses and the tooth 
remain vital. In the past decade, materials such 
as calcium silicate cements like mineral trioxide 
aggregate (MTA) and calcium-enriched mixture 
were introduced as ceramic materials capable of 
repair and induction of regeneration of pulp 
tissue. 
Poly alpha hydroxy ester is a synthetic polymer 
and has three subgroups of aliphatic polyesters, 
polyanhydrides and poly ortho esters. Poly alpha 
hydroxy esters have different types such as 
polyglycolic acid and polylactic acid. Glycolic 
acid and lactic acid are by-products of various 
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metabolic pathways in the human body and are 
eliminated after production. Their main 
difference is in their degradability since 
polyglycolic acid is broken down faster than 
polylactic acid. Behavior and degradability of 
PLGA copolymer is controllable and this 
characteristic is the main advantage of this 
polymer and the reason for its application in 
medicine and dentistry (1-6). Use of 
biodegradable polymers in the form of 
microspheres/microparticles containing drugs in 
novel drug delivery systems enables controlled 
release of drug and is a new approach and an 
alternative to complex medical and dental 
treatments. Microspheres are mainly made of 
PLGA and are used for in vitro cell proliferation. 
They are injected at the injured site for tissue 
repair (7-10).  
Many studies in the fields of pharmaceutics and 
orthopedics have been conducted on the 
production of PLGA microspheres and assessed 
the amount of released antibiotics from loaded 
microspheres. In restorative dental treatments 
and use of pulp capping agents, the main 
objective of treatment is to eliminate 
microorganisms from the pulp chamber and 
induce the formation of dentinal bridge. 
Antibiotic carriers would be ideal for decreasing 
the microbial count as much as possible. 
In general, direct pulp capping has a poor 
prognosis due to the high risk of internal 
resorption, pulp calcification, necrosis and 
damage to the tooth surrounding bone (11-15). 
Nonetheless, direct pulp capping of primary 
teeth is performed by clinicians as a 
conservative pulp treatment (16). However, an 
ideal direct pulp capping agent for primary teeth 
has not yet been introduced (17). PLGA 
microspheres loaded with antibiotics may be 
used for direct pulp capping to increase the 
success of treatment. However, this topic needs 
to be further evaluated. 
In this study, gentamicin was loaded into PLGA 
microspheres and its release pattern was 




In this in-vitro study, the following materials 
were used for the fabrication of PLGA 
microspheres loaded with gentamicin: 
PLGA (RG504H, Sigma Aldrich, MO, USA), 
chloroform (Merck, Germany), gentamicin 
sulfate (SinaDarou, Tehran, Iran), polyvinyl 
alcohol (hydrolyzed 98%-99%; 50000-31000 
MW, Sigma Aldrich, MO, USA) and phosphate 
buffered saline (PBS).  
Preparing gentamicin solution: 
To prepare gentamicin solution, deionized water 
was used in order to prevent the effect of ions on 
the surface of PLGA microspheres. The initial 
water phase included 1cc of polyvinyl alcohol 
(PVA) solution (1%w/v) containing 0.1 g 
gentamicin. The solution was vortexed in order 
for the gentamicin to dissolve completely.  
Preparing PLGA microspheres containing 
gentamicin: 
Microspheres were prepared using double 
emulsion method (W/O/W). In this method, the 
oil phase included 0.2 g PLGA dissolved in 650 
μL chloroform. To produce microspheres, the 
initial water phase (gentamicin solution in PVA) 
was added to the oil phase. The mixture was 
homogenized at 13,000 rpm for one minute 
using a homogenizer (Heidolph, Schwabach, 
Germany) to obtain water-oil (W1/O) emulsion. 
The obtained emulsion was added to 30cc of the 
secondary water phase (0.01% w/v PVA 
solution). 
The W1/O/W2 double emulsion was mixed by a 
magnetic mixer (Heidolph, Schwabach, 
Germany) for 2 hours at room temperature in 
order for the solvent to evaporate. To collect 
microspheres, the obtained emulsion was 
centrifuged at 11,000 rpm for 10 minutes. To 
wash microspheres, this procedure was repeated 
three times (18). The specimens were then 
frozen at -20°C and dried using freeze dryer 
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(Christ, Shropshire, UK) for 48 hours. Next, 
microspheres were thoroughly collected and 
stored at 0°C. 
Particle size and surface morphology: 
SEM (VEGA, TESCAN, LMU, USA) was used 
for assessment of surface morphology. To obtain 
SEM micrographs of PLGA microspheres, 5mg 
of specimens was weighed and placed on a piece 
of aluminum foil. Specimens were gold coated 
and evaluated under SEM in terms of size, shape 
and surface morphology of microspheres. 
Release profile: 
To determine the concentration of drug released 
from the microspheres into the PBS solution, a 
spectrophotometer (Unico 2100uv, New Jersey, 
USA) was used. Based on the results of scanning 
gentamicin in buffered solution, the drug was 
found to have a 330nm wavelength.  
By preparing the stock solution and diluting it, 
different concentrations were obtained and for 
each concentration, drug absorbance at 330nm 
was measured. Standard curve of gentamicin 
concentration based on UV absorbance at 330nm 
was drawn by the spectrophotometer.  
Drug release curve: 
In three small containers, 3mg of PLGA 
microspheres containing gentamicin were added 
to 3mL of PBS solution and placed in incubator 
shaker at 37°C. PBS in each container was 
refreshed at specific time points. To assess the 
amount of released drug, UV spectroscopy was 
performed using a spectrophotometer at 330nm 
wavelength. The drug release measurement was 
performed every other day for 20 days. 
Gentamicin loading: 
To determine the encapsulation efficiency of 
gentamicin, 15 mg of drug-containing 
microspheres was dispersed in 10mL of 5%w/v 
sodium dodecyl sulfate (SDS) in NaOH solution 
and the specimens were then mixed for 12 hours 
by a magnetic mixer for complete degradation of 
particles and release of drug. Twelve hours after 
the degradation, to separate any possible 
remaining particle, the samples were centrifuged 
at 8000 rpm for 5 minutes and the supernatant 
was collected. The amount of drug extracted 
from the microparticles present in the solution 
was measured using a spectrophotometer and 
compared with the baseline value of drug prior 
to loading to assess the amount of loaded drug 
(encapsulation efficiency). 
Encapsulation efficiency (EF)%= 
M     
M    
 ×100 
Statistical analysis: 
Data were analyzed using SPSS version 18. The 
mean, standard deviation, minimum and 
maximum values of released drug at different 
time points were calculated and changes in the 
pattern of drug release at different time points 
were assessed using one way repeated measure 
ANOVA. Type one error was considered as 0.05 





As seen in SEM micrographs, fabricated 
microspheres had a smooth, non-porous surface 
and less than 15-micron diameter. Standard 
concentration curve for gentamicin sulfate based 
on UV absorbance at 330nm wavelength was 
drawn by a spectrophotometer and the following 
equation was obtained: 
Log y=9.6661 log x + 1.450 
Y= concentration 
X= absorbance  
The concentration of gentamicin released from 
the microspheres and the amount of drug loaded 
into the microspheres were calculated using the 
above-mentioned formula. The encapsulation 
efficiency of gentamicin sulfate in the 
microspheres was calculated to be 45%. 
The concentration curve of released drug in 
μg/mL at different time points is shown in 
Diagram 1. Assessment of the pattern of release 
of gentamicin from the microspheres revealed a 
burst release on day six followed by continuous 
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stable release until day 20. The results of 
statistical analyses showed significant 
differences in terms of the concentration of 
released drug at different time points (p=0.004) 
and the release pattern at day six was 
significantly different from that at different time 
points (p<0.001). But, no other significant 
differences were noted in this regard among 
other time points (p=0.098). On day six, burst 
release of gentamicin from PLGA microspheres 
occurred, which is responsible for the significant 
difference in the pattern of release between day 
six and other time points. 
 
Figure 1- SEM micrograph of PLGA 









Biodegradable microspheres are used for 
controlled release and targeted delivery of drugs. 
Considering the need for highly effective 
antimicrobial agents for root canal infections, in 
this study we loaded gentamicin into PLGA 
microspheres.  
Gentamicin has the highest efficacy for use in 
studies on controlled drug release due to its 
broad-spectrum antimicrobial activity, high 
solubility and stability at high temperatures (19). 
Gentamicin has bactericidal effects on aerobic 
Gram-negative and some Staphylococcus 
strains. Despite some previous studies on drug 
release, mechanisms of drug release have yet to 
be fully recognized and control of release is 
difficult to achieve.  
Considering the specific physical and chemical 
properties of gentamicin sulfate, several studies 
have assessed the type of carrier, technique of 
loading, the amount of water phase and 
substantivity of drug. In most previous studies, 
PLGA carriers have been used for loading of this 
drug. Phosphate salt solution has been mainly 
used as gentamicin solvent in previous studies, 
which results in porosities, increased drug 
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current study, PVA solution was used as the 
solvent in order to produce nonporous 
microspheres.  
SEM analysis showed smooth surface and small 
size of microspheres, which is in line with the 
findings of Sivakumar et al. in 2002 (20). Also, 
using homogenizer, small microspheres were 
produced in our study, which was similar to the 
ultrasonic method adopted by Virto et al, in 
2007 (21) with the difference that homogenizer 
used in our study does not destruct polymer 
chains (in contrast to ultrasound).  
Drug loading depends on the size of 
microspheres. The larger the microspheres, the 
greater the amount of loaded drug. This explains 
the lower loading rate of gentamicin in the 
produced microspheres in our study.  
When microspheres are immersed in an aqueous 
environment, water penetrates deep into the 
particles and results in diffusion of drug through 
the microporosities of the polymer. In 
macromolecules, diffusion through the porous 
network is highly limited due to the confined 
space and occurs gradually as the pores become 
larger due to the degradation of polymer. Thus, 
the rate of drug release from the polymeric 
microspheres is mainly controlled by the amount 
of loaded drug, size of polymer, degradation of 
polymer, its porous structure and drug 
penetration. 
Pattern of drug release from the microspheres 
depends on the type of dug, its hydrophobicity/ 
hydrophilicity and manufacturing conditions 
such as type of polymer and method of 
fabrication. In fact, use of PLGA copolymers 
with different molecular weights and 
compositions changes the primary hydration and 
degradation rate of matrix. However, limitations 
in type of PLGA copolymer and method of 
fabrication can be a major obstacle for 
controlled release of drug. In such conditions, 
improving the primary morphology (i.e. 
percentage of primary porosity) or addition of 
factors affecting drug diffusion through the 
polymer matrix may be of great help. 
Gentamicin is a highly hydrophilic antibiotic and 
thus, its loading into the matrix is very important 
and is determined based on its desired release 
rate. Gentamicin-containing microspheres in this 
study were produced in such way that small 
microspheres (30-micron diameter) had the 
lowest encapsulation efficiency. To increase 
encapsulation efficiency, if required, the share of 
water phase must be minimized and large 
microspheres must be produced. In the current 
study, encapsulation efficiency of gentamicin 
was 45% and the release period was 20 days, 
which are similar to the results of Naraharisetti 
et al. in 2005; who reported 50% encapsulation 
efficiency and release period of 15 days from 
paclitaxel loaded poly (L-lactic acid 
(PLLA)microspheres (22). PLGA microspheres 
undergo mass and homogenous degradation due 
to the hydrolysis of ester bonds. In 2002, 
Blanco-Prieto et al. stated that by increasing the 
solubility of gentamicin, loading rate increased, 
which is in contrast to our findings because in 
our study, the highest solubility of gentamicin 
sulfate was considered in the water phase and 
the microspheres were produced (23).  
However, entrapment of gentamicin, its release 
profile and size of microspheres highly depend 
on the method of encapsulation, polymer 
characteristics, biodegradability, position of 
copolymer and its molecular weight (23-25).  
The current study evaluated the release of 
gentamicin from PLGA microspheres at 
different days. Moreover, PLGA powders in 
conjunction with MTA may be suitable for use 
as an acceptable direct pulp capping agent for 
placement at the site of pulp exposure. This 
topic can be the subject of future investigations. 
Based on the results of the current study, the 
concentration of released drug from PLGA 
microspheres was not significantly different 
after day six. Burst release of gentamicin from 
PLGA particles occurred on day six. 
 




PLGA microspheres loaded with gentamicin 
sulfate provide controlled and sustained release 
of drug for over 15 days and thus, they can be 
used for restorative dental treatments such as 
direct pulp capping. 
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